Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 2
2020 3
2021 6
2022 3
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic value of a modified‑immune scoring system in patients with pathological T4 colorectal cancer.
Dorjkhorloo G, Erkhem-Ochir B, Shiraishi T, Sohda M, Okami H, Yamaguchi A, Shioi I, Komine C, Nakazawa N, Ozawa N, Shibasaki Y, Okada T, Osone K, Sano A, Sakai M, Ogawa H, Yokobori T, Shirabe K, Saeki H. Dorjkhorloo G, et al. Among authors: erkhem ochir b. Oncol Lett. 2024 Jan 17;27(3):104. doi: 10.3892/ol.2024.14237. eCollection 2024 Mar. Oncol Lett. 2024. PMID: 38298428 Free PMC article.
HLA Class I Expression Is Associated with DNA Damage and Immune Cell Infiltration into Dysplastic and Neoplastic Lesions in Ulcerative Colitis.
Okami H, Ozawa N, Sohda M, Yokobori T, Osone K, Erkhem-Ochir B, Dorjkhorloo G, Shiraishi T, Okada T, Sano A, Sakai M, Miyazaki T, Ogawa H, Yao T, Oike T, Sato H, Shirabe K, Shibata A, Saeki H. Okami H, et al. Among authors: erkhem ochir b. Int J Mol Sci. 2023 Sep 4;24(17):13648. doi: 10.3390/ijms241713648. Int J Mol Sci. 2023. PMID: 37686454 Free PMC article.
MAdCAM-1 targeting strategy can prevent colitic cancer carcinogenesis and progression via suppression of immune cell infiltration and inflammatory signals.
Ozawa N, Yokobori T, Osone K, Bilguun EO, Okami H, Shimoda Y, Shiraishi T, Okada T, Sano A, Sakai M, Sohda M, Miyazaki T, Ide M, Ogawa H, Yao T, Oyama T, Shirabe K, Saeki H. Ozawa N, et al. Among authors: bilguun eo. Int J Cancer. 2024 Jan 15;154(2):359-371. doi: 10.1002/ijc.34722. Epub 2023 Sep 7. Int J Cancer. 2024. PMID: 37676657
High RRN3 expression is associated with malignant characteristics and poor prognosis in pancreatic cancer.
Batbayar C, Ishii N, Harimoto N, Yokobori T, Saito H, Gantumur D, Gombodorj N, Erkhem-Ochir B, Muranushi R, Hoshino K, Yamanaka T, Hagiwara K, Tsukagoshi M, Watanabe A, Araki K, Hosouchi Y, Shirabe K. Batbayar C, et al. Among authors: erkhem ochir b. Int J Clin Oncol. 2023 Jul;28(7):901-912. doi: 10.1007/s10147-023-02342-w. Epub 2023 Apr 29. Int J Clin Oncol. 2023. PMID: 37119370
Comprehensive expressional analysis of chemosensitivity-related markers in large cell neuroendocrine carcinoma of the lung.
Ohtaki Y, Kaira K, Yajima T, Erkhem-Ochir B, Kawashima O, Kamiyoshihara M, Igai H, Onozato R, Ibe T, Kosaka T, Nakazawa S, Nagashima T, Oyama T, Shirabe K. Ohtaki Y, et al. Among authors: erkhem ochir b. Thorac Cancer. 2021 Oct;12(20):2666-2679. doi: 10.1111/1759-7714.14102. Epub 2021 Aug 28. Thorac Cancer. 2021. PMID: 34453496 Free PMC article.
17 results